Small Intestinal Bacterial Overgrowth Diagnostics Market Analysis And Forecast To 2032: By Service (Breath Testing, Small Intestine Aspirate and Fluid Culture Test, Blood Test, Others), By Application (Hydrogen-Predominant SIBO, Methane-Predominant SIBO,

Small Intestinal Bacterial Overgrowth Diagnostics Market Analysis And Forecast To 2032: By Service (Breath Testing, Small Intestine Aspirate and Fluid Culture Test, Blood Test, Others), By Application (Hydrogen-Predominant SIBO, Methane-Predominant SIBO, Recurrent SIBO), And By Region

The global small intestinal bacterial overgrowth diagnostics market was valued at USD 1,38,324.2 Thousand in 2022 and it is anticipated to grow up to USD 2,44,337.1 Thousand by 2032, at a CAGR of 5.9% during the forecast period.

Small intestinal bacterial overgrowth (SIBO) is defined as the presence of excessive bacteria in the small intestine. SIBO is frequently implicated as the cause of chronic diarrhea and malabsorption. Patients with SIBO may also suffer from unintentional weight loss, nutritional deficiencies, and osteoporosis.

Global Small Intestinal Bacterial Overgrowth Diagnostics Market Scope and Report Structure

Market Trends and Drivers

The market's growth is primarily attributed to the increasing prevalence of conditions such as immunodeficiency syndromes and pancreatic exocrine insufficiency amongst others. Growing prevalence of risk factors associated with the SIBO are also expected to drive the prevalence of the condition, which will eventually offer favorable environment for growth of US small intestinal bacterial overgrowth diagnostics market by 2027. For instance, according to a study published by group of researchers at Northwell Health System, Division of Gastroenterology, New York in 2017, obesity is one of the prominent causes and risk factors to drive the bacterial overgrowth in small intestine. Small intestinal bacterial overgrowth (SIBO) has been incorporated with anatomical and motility-related abnormalities. Mainly, obesity has been proposed to change small bowel motility, leading to SIBO. As a result, SIBO was more frequent amongst obese patients vs. non-obese patients (88.9% vs. 42.9%). Obese vs. non-obese patients presented notable differences in microbiome diversity in rectal samples. Obesity was connected with increased odds of developing SIBO. Therefore, rising prevalence of obesity will ultimately offer a lucrative opportunity for growth of the market. Growing prevalence of IBS and SIBO and increasing advantages of breath test are the major factor driving the growth of the North America small intestinal bacterial overgrowth (SIBO) diagnostics market.

Market Restraints and Challenges

Small intestinal bacterial overgrowth (SIBO) can cause escalating problems, including: Poor absorption of fats, carbohydrates and proteins. Bile salts, which are normally needed to digest fats, are broken down by the excess bacteria in your small intestine, resulting in incomplete digestion of fats and diarrhea. Thus, the side effects associated with the test is likely to hinders the markets growth.

Global Small Intestinal Bacterial Overgrowth Diagnostics Market Segmental Overview

The report analyses the global Small Intestinal Bacterial Overgrowth Diagnostics market based on diagnosis, type, and region

Global Small Intestinal Bacterial Overgrowth Diagnostics Market by Diagnosis

Based on diagnosis, the SIBO diagnostics market is segmented into breath testing, small intestine aspirate and fluid culture test, blood test, and others. In 2022, the breath testing segment held the largest share of the market and is expected to grow at the fastest rate during the coming years. The growth is attributed due to its advantages, such as non-invasive, patient-friendly, simplicity, and low-cost. Hydrogen breath tests for carbohydrate malabsorption, and lactulose and glucose hydrogen breath tests for bacterial growth are the widely used breath tests. Of these, the lactulose hydrogen breath test is less specific than the glucose hydrogen breath test. According to a study, 'Breath Tests for the Non-invasive Diagnosis of Small Intestinal Bacterial Overgrowth: A Systematic Review with Meta-analysis,' published in January 2020, glucose hydrogen breath test has a sensitivity of 58% and specificity of 83%, compared with 42% sensitivity and specificity of 70% for lactulose hydrogen breath test. These tests are also widely used to detect other digestive disorders, including intestinal methanogen overgrowth (IMO), abnormal digestion of dietary sugars, and rapid small bowel transit time. Moreover, these tests help in diagnosing IBS by identifying primitive hypersensitivity. Thus, owing to the benefits, breath tests are likely to propel the growth of market during the forecast period.

Global Small Intestinal Bacterial Overgrowth Diagnostics Market by Type

Based on type, the SIBO diagnostics market is segmented into hydrogen-predominant SIBO, methane-predominant SIBO, and recurrent SIBO. In 2022, the hydrogen-predominant SIBO segment held the largest share of the market and the same segment is expected to grow at the fastest rate during the coming years. Hydrogen-predominant small intestinal bacterial overgrowth (SIBO) is most common due to increased dietary sugar intake and processed foods. These foods provide an ideal environment for bacterial growth and can cause an overgrowth of bacteria in the small intestine leading to loss of appetite, discomfort, and bloating. Moreover, Imbalances in gut bacteria can also be caused by age, antibiotic use, and digestive disorders such as irritable bowel syndrome.

Geographical Analysis of Global Small Intestinal Bacterial Overgrowth Diagnostics Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. In 2022, in 2021, the North America region led the small intestinal bacterial overgrowth diagnostics market. There has been a constant development in SIBO diagnostics. The currently used breath test has low sensitivity and specificity. Therefore, the additional validation studies are undergoing to define standard protocols. The growing technological developments in the field of medical devices have offered various innovative products to diagnose several complex human health conditions. Thus, to diagnose SIBO, an innovative orally ingested capsule technology is in the developmental process. It is designed in a way to measure in vivo hydrogen and carbon-di-oxide after ingestion of a carbohydrate meal and provide a technologically updated alternative to the current breath hydrogen test. It is expected that the capsule technology will help in diagnosing samples of small bowel bacteria. Thus, the introduction of capsule technology is likely to emerge in the coming future and contribute to direct and accurate evaluation of SIBO and offer vital growth opportunities for the North America market growth.

Major Players in the Global Small Intestinal Bacterial Overgrowth Diagnostics Market

The key players in the market  Genova Diagnostics, SIBO Diagnostics, Commonwealth Diagnostics International, Aerodiagnostics, LLC, SIBOTest, Metabolic Solutions, Inc., Pivotal Diagnostics, DirectLabs, LLC, Vibrant Wellness. And Health Associates Medical Group, among others.

COVID-19 Impact:

In case of COVID-19, North America is highly affected specially the US. Industrial sectors in the countries such as the US and Canada has experienced disruption in various industries, including healthcare. However, the need for diagnosis and treatment for the COVID positive patients has carried on business cycles in the medical sector. In addition, the rising demand for personal protective equipment has tried to stabilize the business cycle for the healthcare industry. According to an article issued by Harvard Medical School, infectious viral particles can live in the air for three hours. As a result, it can cause patient scheduling obstructions and put others at risk for contracting the virus. For healthcare providers demanding to test for GI-related problems offered by patients, a substitute for in-office breath testing must be granted due to the potential spread of COVID-19 through aerosolization. Unfortunately, the possible aerosolization spread of COVID-19 makes breath testing in-office comparatively unsafe and has been in a bit of a dilemma in the clinic during this pandemic. The small intestinal bacterial overgrowth diagnostics market also witnessed major decline due to lowered number of diagnostic procedures.

Substantial focus on management of COVID had direct impact on diagnostics of abdominal conditions such as irritable bowel syndrome, SIBO, and lactose intolerance. In addition, patients showed reluctance for breath and blood tests due to fear of COVID infection. These factors consequently led to adverse impact on North America small intestinal bacterial overgrowth market during the pandemic period. However, the market is expected to witness considerable growth post-pandemic. Certain factors such as rise in prevalence of SIBO and IBS are estimated to show positive impact on market growth.

Recent Developments:

• In February 2022, FoodMarble, a digital health company in the gastroenterology space, has launched a personal digestive breath tester: AIRE 2.

Frequently Asked Questions

Q1.

How big is the Small Intestinal Bacterial Overgrowth Diagnostics Market?

Ans.

The global Small Intestinal Bacterial Overgrowth Diagnostics market was valued at USD 1,38,324.2 Thousand in 2022 and it is anticipated to grow up to USD 2,44,337.1 Thousand by 231.4, at a CAGR of 5.9% during the forecast period.

Q2.

What is the Small Intestinal Bacterial Overgrowth Diagnostics Market growth rate?

Ans.

The growth rate of the Small Intestinal Bacterial Overgrowth Diagnostics Market is 5.9%

Q3.

Which region holds a major market share for the market?

Ans.

North America holds a major market share of the Small Intestinal Bacterial Overgrowth Diagnostics Market in 2022.

Q4.

Which segment accounted for the largest Small Intestinal Bacterial Overgrowth Diagnostics Market share?

Ans.

By type, the Hydrogen-Predominant SIBO segment accounted for the largest Small Intestinal Bacterial Overgrowth Diagnostics Market share.

Q5.

Who are the key players in the Small Intestinal Bacterial Overgrowth Diagnostics Market?

Ans.

The global Small Intestinal Bacterial Overgrowth Diagnostics Market report includes players such as Genova Diagnostics, SIBO Diagnostics, Commonwealth Diagnostics International, Aerodiagnostics, LLC, SIBOTest, Metabolic Solutions, Inc., Pivotal Diagnostics, DirectLabs, LLC, Vibrant Wellness. And Health Associates Medical Group. among others.

Q6.

What are the factors driving the Small Intestinal Bacterial Overgrowth Diagnostics Market growth?

Ans.

The major factors driving the growth of the market are cost-effectiveness has increased the adoption of a breath test in clinical practice.

Q7.

What are the key growth strategies of Small Intestinal Bacterial Overgrowth Diagnostics Market players?

Ans.

The key growth strategies of Small Intestinal Bacterial Overgrowth Diagnostics Market players are product launch and product approval.

Q8.

Which region will provide more business opportunities for the Small Intestinal Bacterial Overgrowth Diagnostics Market during the forecast period?

Ans.

The Asia-Pacific region will provide more business opportunities for the Small Intestinal Bacterial Overgrowth Diagnostics Market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.